Virtual Specialist Conferences Between General Practitioners and Endocrinologists About Type 2.Diabetes: a Pragmatic Randomized Controlled Trial

Registration

Registration

NCT05268081

Acronym

STAR

Study type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Status

COMPLETED

Enrollment

25

Start

2022-01-01

Primary completion

2023-08-30

Lead sponsor

University of Aarhus

Conditions

Diabetes Mellitus, Type 2

Interventions

OTHER:Virtual specialist conferences

Results posted

FALSE

Individual participant data sharing

NO

Registered primary outcomes

• Ischemic heart disease and/or stroke treated with GLP1-RA and SGLT2 inhibitor [Month 12]
• Micro/macro-albuminuria treated with ACE-inhibitor or AT2 [Month 12]
• LDL>2.5 mmol/L treated with Statins [Month 12]
• Questionnaire for the assessment of general practitioners' confidence in managing type-2 diabetes in general [Month 12]
• Questionnaire for the assessment of general practitioners' skills in managing type-2 diabetes in general [Month 12]
• Questionnaire for the assessment of general practitioners' confidence in managing type-2 diabetes and cardiovascular disease or heart failure [Month 12]
• Questionnaire for the assessment of general practitioners' confidence in managing type-2 diabetes and blood pressure [Month 12]
• Questionnaire for the assessment of general practitioners' confidence in managing type-2 diabetes and kidney disease [Month 12]
• Questionnaire for the assessment of general practitioners' confidence in managing type-2 diabetes and cholesterol [Month 12]